Recent cases involving sick children made it clear to me that our position on cannabis-related medicinal products was not satisfactory.
What we have begun to see is a geographical division in the availability of care packages dependant on your address
“The ACMD agrees with the Chief Medical Officer for England (CMO) that there is now evidence of medicinal benefit for some Cannabis-derived products in certain medical conditions for some patients.”
The Controlled Substances Act of 1970 classified all forms of cannabis as a Schedule I drug, making it illegal to grow it in the United States.3
“We found that cannabis exposure caused more frequent, small meals,”
“It’s designed to bring people together to hear uplifting messages about healing from experts in the field of natural entheogenic and psychedelic medicines, to connect with one another and to feel free… this is awakening to our true nature as human beings.”
The fight goes on, but at least we may have a few more allies as we push forward.
Maybe…but probably not.
“We hope that this will be a new and meaningful treatment option available on prescription and increase the range of options for doctors and patients alike as they navigate their cancer care.”
I’m involved in the Israeli medicinal cannabis industry from its infancy and actively been developing technologies for products and projects worldwide